The current P/E ratio of CRGX cannot be calculated, as the latest EPS of -$4.62 is negative. CARGO Therapeutics's last PE ratio on record was 0.23 in September 2024.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $14.42 | -$3.72 |
2023 | N/A | N/A | $23.15 | -$16.53 |
2022 | N/A | N/A | N/A | -$104.4 |
2021 | N/A | N/A | N/A | -$2.83 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | N/A | N/A | $4.07 | -$4.62 |
Dec 2024 | N/A | N/A | $14.42 | -$3.72 |
Sep 2024 | 0.23 | -54.9% | $18.45 | $78.85 |
Jun 2024 | 0.51 | -84.4% | $16.42 | $32.36 |
Mar 2024 | 3.27 | N/A | $22.32 | $6.82 |
Dec 2023 | N/A | N/A | $23.15 | -$16.53 |
Sep 2023 | N/A | N/A | N/A | -$120.53 |
Jun 2023 | N/A | N/A | N/A | -$101.54 |
Mar 2023 | N/A | N/A | N/A | N/A |
Dec 2022 | N/A | N/A | N/A | -$104.4 |
Sep 2022 | N/A | N/A | N/A | N/A |
Dec 2021 | N/A | N/A | N/A | -$2.83 |
Stock name | PE ratio | Market cap |
---|---|---|
NVAX Novavax Inc | 2.34 | $1.15B |
BIIB Biogen Inc | 13.32 | $19.83B |
REGN Regeneron Pharmaceuticals Inc | 13.4 | $60.43B |
GILD Gilead Sciences Inc | 24.01 | $142.48B |
AMGN Amgen Inc | 27.18 | $161.51B |
VRTX Vertex Pharmaceuticals Inc | N/A | $123.14B |
ALNY Alnylam Pharmaceuticals Inc | N/A | $42.07B |
MRNA Moderna Inc | N/A | $13.26B |
SRPT Sarepta Therapeutics Inc | N/A | $1.87B |
CRGX CARGO Therapeutics Inc | N/A | $212.12M |
The current price to earnings ratio of CRGX cannot be determined, as its EPS of -$4.62 is negative.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.